Vaxart (NASDAQ: VXRT) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $2.18 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.